BBA
APLT

Baker Bros. Advisors’s Applied Therapeutics APLT Stock Holding History

Baker Bros. Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-38,034
Closed -$790K – 127
2020
Q3 		$790K Sell
38,034
-27,900
-42% -$725K ﹤0.01% 113
2020
Q2 		$2.38M Hold
65,934
– – 0.01% 99
2020
Q1 		$2.15M Buy
+65,934
New +$2.67M 0.01% 89

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Baker Bros. Advisors's APLT Position: Q4 2020 in Review

Baker Bros. Advisors sold out of Applied Therapeutics (APLT) in Q4 2020, closing a stake of 38,034 shares — an estimated $790K sold.

Baker Bros. Advisors first reported a position in APLT in Q1 2020 and held it in 3 quarters. The position peaked at $2.38M in Q2 2020. 67 funds tracked by Wall St. Rank hold APLT as of Q4 2020.

  • Baker Bros. Advisors reported no remaining Applied Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Baker Bros. Advisors sold 38,034 Applied Therapeutics shares in Q4 2020, an estimated $790K.
  • Baker Bros. Advisors first reported a position in Applied Therapeutics in Q1 2020 and held it in 3 quarters.
  • Baker Bros. Advisors's Applied Therapeutics position peaked at $2.38M in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2020.

Based on Baker Bros. Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.